Drug Efficacy

Weight Loss Medications Patient Outcomes Adverse Effects Cognitive Decline Chronic Diseases Research Developments

Novo Nordisk Launches Oral Wegovy Pill in UAE, Its First Market Outside the U.S.

The UAE approval opens a non‑injectable option for long‑term weight management and signals a staged international rollout guided by local health‑system readiness.

5 ARTICLES

6mo ago

FDA Approves First Oral Wegovy Weight-Loss Pill as U.S. Availability Begins